Veeva Systems Inc.

Veeva said total revenue for the quarter was $883 million and non-GAAP operating income was $395 million, and Peter Gassner said results were ahead of guidance. No EPS or gross margin figure was stated in the call discussion. For the year, Brian Van Wagener said Ostro is expected to contribute about $10 million in the remaining 3 quarters and about 2/3 of the $15 million increase in commercial subscription revenue guidance. He also said AI revenue outside of Ostro is expected to be fairly immaterial this year, and that AI should not have a material impact on margins in FY2027.

Peter Gassner framed the quarter as the start of a broader strategic shift toward “software, AI, data and consulting,” with Falcon representing Veeva’s move into agentic labor. He emphasized that Veeva is aiming to standardize and simplify industry workflows rather than provide generic AI tooling, and repeatedly described Falcon as disruptive rather than incremental. His tone was highly confident and expansionary, stressing that the company has a structural advantage because it already has deep life-sciences expertise, consulting, and the applications agents will use.

Brian Van Wagener pointed to a healthy macro backdrop and said the environment was unchanged from when guidance was set, with strong execution across commercial, DevCloud and Quality. He explained that R&D growth is being driven by several large but still early-stage products such as eCOA, RTSM, EDC, Safety and LIMS, while services outperformance came from strong project execution in R&D and business consulting, plus some uplift from Vault CRM migrations. On margins, he said the main year-over-year pressure came from services investments and a tougher compare in subscriptions after last year’s breakout Crossix quarter; he also said AI token costs are already reflected in guidance and should not materially affect margins this year.

Analysts focused on Falcon’s use cases, pricing, customization, cannibalization risk, and whether AI could reshape the commercial and development ecosystems. Management said Falcon will likely be priced by document or by case, starts with high-volume repetitive work like clinical document processing, safety cases and regulatory correspondence, and is intended to be accretive rather than cannibalistic because it addresses work Veeva does not currently supply. On CRM, Paul Shawah said the company still expects to win the majority of the four remaining top-20 decisions, cited more than 150 live Vault CRM customers and over 40 migrations, and said the win rate is over 80%.